Madison El-Saadi
Stock Analyst at B. Riley Securities
(4.45)
# 458
Out of 5,182 analysts
16
Total ratings
68.75%
Success rate
21.44%
Average return
Main Sectors:
Stocks Rated by Madison El-Saadi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CMPS COMPASS Pathways | Initiates: Buy | $17 | $8.44 | +101.42% | 1 | Apr 24, 2026 | |
| ETON Eton Pharmaceuticals | Maintains: Buy | $26 → $31 | $24.16 | +28.31% | 4 | Mar 20, 2026 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $50 → $63 | $33.98 | +85.40% | 3 | Mar 13, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $61 → $101 | $70.13 | +44.02% | 1 | Jan 22, 2026 | |
| VNDA Vanda Pharmaceuticals | Maintains: Buy | $11 → $14 | $6.84 | +104.68% | 2 | Dec 31, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $19 → $37 | $7.52 | +392.02% | 4 | Dec 12, 2025 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $179 | $185.00 | -3.24% | 1 | Oct 1, 2025 |
COMPASS Pathways
Apr 24, 2026
Initiates: Buy
Price Target: $17
Current: $8.44
Upside: +101.42%
Eton Pharmaceuticals
Mar 20, 2026
Maintains: Buy
Price Target: $26 → $31
Current: $24.16
Upside: +28.31%
Capricor Therapeutics
Mar 13, 2026
Maintains: Buy
Price Target: $50 → $63
Current: $33.98
Upside: +85.40%
Arrowhead Pharmaceuticals
Jan 22, 2026
Maintains: Buy
Price Target: $61 → $101
Current: $70.13
Upside: +44.02%
Vanda Pharmaceuticals
Dec 31, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $6.84
Upside: +104.68%
Wave Life Sciences
Dec 12, 2025
Maintains: Buy
Price Target: $19 → $37
Current: $7.52
Upside: +392.02%
Axsome Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $179
Current: $185.00
Upside: -3.24%